FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental ANDA for levothyroxine sodium from Mylan Pharmaceuticals, authorizing the marketing of a generic levothyroxine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Drugs mentioned

• LEVOTHYROXINE SODIUM (levothyroxine sodium)

Snippet

SUPPL AP for LEVOTHYROXINE SODIUM (LEVOTHYROXINE SODIUM)